Floatz logo

Epinephrine

Lymphoma

National Cancer Institute (NCI)Small moleculePhase 1Dormant
CC
40/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
65/ 100

Competitive context

289 Active assets in the Lymphoma cohort.

View all 50

Same molecule, other indications

Epinephrine is also rated in:

Pain, PostoperativeDormant
BBB
Indicative ·
72 / 100
View asset →
digestive system disorderDormant
BB
Indicative ·
68 / 100
View asset →
Crohn diseaseDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →